• AN2 Therapeutics Slides 5.96% as Biotech Headwinds Pressure ANTX Shares - Naked POC dars.gov.et Fri, 03 Jul 2026 17:41:23 GMT
• antx stock records biggest ever single day gain, surges 500% over past four sessions – what triggered this smashing rally? Stocktwits Fri, 03 Jul 2026 14:12:33 GMT
• an2 therapeutics, inc.(nasdaqgs:antx) added to russell microcap growth benchmark index marketscreener.com Mon, 29 Jun 2026 12:32:36 GMT
• AN2 Therapeutics, Inc.(NasdaqGS: ANTX) added to Russell 2000 Growth Benchmark marketscreener.com Mon, 29 Jun 2026 11:24:05 GMT
• antx stock records biggest ever single day gain, surges 500% over past four sessions – what triggered this smashing rally? Stocktwits Sun, 28 Jun 2026 12:59:57 GMT
• an2 therapeutics, inc. actuals & estimates (nasdaq:antx) TradingView Fri, 26 Jun 2026 08:10:21 GMT
• Price to earnings forward of AN2 Therapeutics, Inc. – NASDAQ:ANTX TradingView Fri, 26 Jun 2026 04:45:16 GMT
• AN2 Therapeutics (ANTX) Edges Higher Amid Consolidation Near Support - Descending Triangle dars.gov.et Wed, 24 Jun 2026 07:00:00 GMT
• AN2 Therapeutics Edges Higher, Testing Resistance Near $5.25 - Dark Pool Prints dars.gov.et Sat, 20 Jun 2026 07:00:00 GMT
• an2 therapeutics inc (antx) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 21:57:28 GMT
• an2 therapeutics inc (antx) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 21:52:05 GMT
• an2 therapeutics inc (antx) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 21:52:02 GMT
• an2 therapeutics inc (antx) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 21:49:44 GMT
• an2 therapeutics inc (antx) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 21:31:53 GMT
• an2 therapeutics inc (antx) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 05:27:16 GMT
• an2 therapeutics inc (antx) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 05:19:26 GMT
• an2 therapeutics inc (antx) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 04:50:27 GMT
• an2 therapeutics inc. (antx) q1 2026 earnings: eps misses estimates as pre-revenue biotech advances lead compound - post-earnings ... newsline.com Tue, 16 Jun 2026 12:30:34 GMT
• antx stock records biggest ever single day gain, surges 500% over past four sessions – what triggered this smashing rally? Stocktwits Tue, 16 Jun 2026 06:37:25 GMT
• an2 therapeutics inc (antx) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• number of shareholders of an2 therapeutics, inc. – nasdaq:antx TradingView Sat, 13 Jun 2026 17:30:36 GMT
• an2 rises after early-stage trial data for chagas disease therapy MSN Thu, 11 Jun 2026 23:12:42 GMT
• an2 therapeutics holds 2026 annual stockholder meeting The Globe and Mail Wed, 10 Jun 2026 10:48:00 GMT
• an2 rises after early-stage trial data for chagas disease therapy MSN Tue, 09 Jun 2026 19:04:09 GMT
• an2 rises after early-stage trial data for chagas disease therapy MSN Mon, 08 Jun 2026 21:05:30 GMT
• shareholders back an2 therapeutics (nasdaq: antx) directors and auditor Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• an2 rises after early-stage trial data for chagas disease therapy MSN Sun, 07 Jun 2026 08:19:24 GMT
• antx stock records biggest ever single day gain, surges 500% over past four sessions – what triggered this smashing rally? Stocktwits Fri, 05 Jun 2026 23:46:06 GMT
• an2 therapeutics advances oral drug candidate an2-502998 to phase 2 trial for chagas disease geneonline.com Fri, 05 Jun 2026 06:51:16 GMT
• antx: three phase ii programs targeting major unmet needs will deliver key data readouts starting this year TradingView Thu, 04 Jun 2026 18:18:41 GMT
• an2 therapeutics reports positive efficacy for chagas candidate an2-502998 grafa.com Thu, 04 Jun 2026 15:34:00 GMT
• one-month oral chagas treatment clears parasite in primates Stock Titan Thu, 04 Jun 2026 11:00:00 GMT
• AN2 Therapeutics Reports Positive Enabling Data Supporting Advancement of Oral AN2-502998 to Phase 2 Study for Chronic Chagas Dise... Business Wire Thu, 04 Jun 2026 07:00:00 GMT
• an2 therapeutics reports positive chagas disease trial results Investing.com Thu, 04 Jun 2026 07:00:00 GMT
• an2 therapeutics (nasdaq: antx) posts strong early chagas trial data Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• an2 therapeutics advances chagas candidate after positive trials TipRanks Thu, 04 Jun 2026 07:00:00 GMT
• an2 therapeutics shares slip; pipeline update due this week may be next driver Bez Kabli Wed, 03 Jun 2026 07:00:00 GMT
• an2 therapeutics (antx) officer sells 265 shares to cover rsu taxes Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• an2 therapeutics (antx) drops 3.3% – support tested amid biotech sector pressure - overbought signal alerts newsline.com Tue, 02 Jun 2026 07:00:00 GMT
• an2 therapeutics (antx) slides 2.9% as shares test key support near $4.11 - sweep order flow The Legal Advocate Fri, 29 May 2026 20:47:05 GMT
• AN2 Therapeutics (ANTX) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances Pipeline - Earnings Beat Alert dars.gov.et Fri, 29 May 2026 07:00:00 GMT
• an2 therapeutics (antx) slides 4.3% as shares test key support at $4.21 - statistical arbitrage The Legal Advocate Thu, 28 May 2026 19:43:18 GMT
• AN2 Therapeutics (ANTX) Slides 2.7% as Shares Test Support Near $4.27 - Value Area High dars.gov.et Thu, 28 May 2026 07:00:00 GMT
• an2 therapeutics (antx) eases 2.1%, testing key support near $4.40 - butterfly setup newsline.com Wed, 27 May 2026 07:00:00 GMT
• an2 therapeutics stock slips modestly amid consolidation near support levels (antx) - iv spike newsline.com Mon, 25 May 2026 07:00:00 GMT
• an2 therapeutics (antx) slips amid biotech sector headwinds; key support levels in focus - sentiment shift newsline.com Fri, 22 May 2026 07:00:00 GMT
• an2 therapeutics (antx) rallies 5% as bulls test critical resistance at $5.40 - quality etf The Legal Advocate Fri, 22 May 2026 07:00:00 GMT
• biotech ceo eric easom to speak at jefferies global healthcare conference Stock Titan Thu, 21 May 2026 11:00:00 GMT
• AN2 Therapeutics to Present at 2026 Jefferies Global Healthcare Conference Business Wire Thu, 21 May 2026 07:00:00 GMT
• an2 therapeutics q1 2026 earnings: wider-than-expected loss as pre-revenue biotech advances pipeline The Legal Advocate Thu, 21 May 2026 07:00:00 GMT
• an2 thera (antx) q1 2026 earnings: miss sparks concern - earnings stability report newsline.com Wed, 20 May 2026 07:00:00 GMT
• an2 thera (antx) stock analysis: climbs +1.76%, eyes on $4.86 2026-05-20 - elliott wave entry The Legal Advocate Wed, 20 May 2026 07:00:00 GMT
• an2 thera (antx) q1 2026 earnings miss: eps $-0.29 vs $-0.23 expected - {璐㈡姤鍓爣棰榼 Newser Mon, 18 May 2026 18:40:06 GMT
• leerink partners maintains an2 therapeutics(antx.us) with buy rating, maintains target price $9 富途牛牛 Mon, 18 May 2026 14:54:27 GMT
• an2 thera (antx) q1 2026 results fall short — eps $-0.29, revenue $n/a - positive surprise momentum newsline.com Mon, 18 May 2026 07:00:00 GMT
• almitas capital holds 4.1% of an2 therapeutics (nasdaq: antx) Stock Titan Sat, 16 May 2026 02:04:08 GMT
• leerink partners maintains an2 therapeutics(antx.us) with buy rating, maintains target price $9 富途牛牛 Fri, 15 May 2026 15:33:00 GMT
• leerink partners upgrades an2 therapeutics(antx.us) to buy rating, announces target price $9 富途牛牛 Fri, 15 May 2026 13:46:26 GMT
• almitas capital holds 4.1% of an2 therapeutics (nasdaq: antx) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• antx upgraded by leerink partners -- price target announced at $9.00 GuruFocus Fri, 15 May 2026 06:14:01 GMT
• leerink downgrades an2 therapeutics to outperform from market perform, adjusts price target to $9 from $1 marketscreener.com Thu, 14 May 2026 11:05:00 GMT
• leerink partners upgrades an2 therapeutics to outperform from market perform, adjusts price target to $9 from $1 marketscreener.com Thu, 14 May 2026 07:00:00 GMT
• leerink partners upgrades an2 therapeutics(antx.us) to buy rating, announces target price $9 Moomoo Thu, 14 May 2026 07:00:00 GMT
• an2 therapeutics reports first quarter 2026 financial results and recent business and scientific highlights BioSpace Tue, 12 May 2026 07:00:00 GMT
• an2 therapeutics inc (nasdaq:antx) pipeline progress outshines slight q1 earnings miss ChartMill Mon, 11 May 2026 20:56:19 GMT
• an2 therapeutics reports $246.8 million cash balance and progress in epetraborole clinical trial geneonline.com Mon, 11 May 2026 20:50:00 GMT
• an2 therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Mon, 11 May 2026 20:08:00 GMT
• an2 pursues chagas treatment and 3 phase 2 programs with cash to 2029 Stock Titan Mon, 11 May 2026 20:01:00 GMT
• AN2 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business and Scientific Highlights Business Wire Mon, 11 May 2026 07:00:00 GMT
• an2 therapeutics (nasdaq: antx) posts q1 loss, extends cash runway and advances pipeline Stock Titan Mon, 11 May 2026 07:00:00 GMT
• an2 therapeutics ($antx) releases q1 2026 earnings Quiver Quantitative Mon, 11 May 2026 07:00:00 GMT
• an2 therapeutics (antx) trims q1 loss, raises $40m and advances phase 2 plans Stock Titan Mon, 11 May 2026 07:00:00 GMT
• how an2 thera (antx) performance reflects its true potential (grinds lower) 2026-05-08 - low vol etf newsline.com Fri, 08 May 2026 07:00:00 GMT
• an2 ceo eric easom joins stifel oncology forum webcast may 19 Stock Titan Thu, 07 May 2026 07:00:00 GMT
• an2 therapeutics to participate in 2026 stifel virtual targeted oncology forum Business Wire Thu, 07 May 2026 07:00:00 GMT
• an2 therapeutics completes first-in-human trial, setting up the next catalyst for antx The Globe and Mail Fri, 01 May 2026 07:00:00 GMT
• an2 therapeutics completes first-in-human trial, setting up the next catalyst for antx TipRanks Thu, 30 Apr 2026 07:00:00 GMT
• an2 therapeutics inc expected to post a loss of 23 cents a share - earnings preview TradingView Wed, 29 Apr 2026 20:02:12 GMT
• an2 therapeutics stock jumps 90% monday: what's driving the action? MSN Wed, 29 Apr 2026 15:48:22 GMT
• new enpp1 inhibitors disclosed in an2 therapeutics patent BioWorld News Tue, 28 Apr 2026 13:00:00 GMT
• an2 therapeutics stock jumps 90% monday: what's driving the action? MSN Sun, 26 Apr 2026 06:52:00 GMT
• an2 therapeutics stock jumps 90% monday: what's driving the action? MSN Fri, 24 Apr 2026 06:14:07 GMT
• an2 therapeutics stock jumps 90% monday: what's driving the action? MSN Thu, 23 Apr 2026 18:49:58 GMT
• an2 therapeutics (antx) details 2026 meeting, board elections and pay Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
• an2 therapeutics (nasdaq: antx) registers 14.04m shares for resale by holders Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
• an2 therapeutics (nasdaq: antx) files $80m at‑the‑market offering Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
• an2 therapeutics enters open market sale agreement with jefferies marketscreener.com Mon, 20 Apr 2026 07:00:00 GMT
• an2 therapeutics, inc. has entered into an at-the-market offering sales agreement with jefferies llc. Bitget Mon, 20 Apr 2026 05:48:01 GMT
• an2 thera (antx) stock under pressure (investors pile in) 2026-04-18 - hot community stocks Cổng thông tin điện tử tỉnh Lào Cai Sat, 18 Apr 2026 14:43:16 GMT
• an2 therapeutics stock jumps 90% monday: what's driving the action? MSN Sat, 18 Apr 2026 02:15:33 GMT
• 12 health care stocks moving in friday's pre-market session Benzinga Fri, 17 Apr 2026 07:00:00 GMT
• an2 therapeutics stock jumps 90% monday: what's driving the action? MSN Fri, 17 Apr 2026 05:30:52 GMT
• an2 therapeutics stock jumps 90% monday: what's driving the action? MSN Wed, 15 Apr 2026 01:37:41 GMT
• antx technical analysis | trend, signals & chart patterns | an2 therapeutics inc (nasdaq:antx) ChartMill Mon, 13 Apr 2026 07:00:00 GMT
• director at an2 therapeutics (nasdaq: antx) awarded 3,775 shares Stock Titan Sat, 11 Apr 2026 01:16:03 GMT
• an2 therapeutics (antx) director receives 3,775-share fully vested grant Stock Titan Sat, 11 Apr 2026 01:16:02 GMT
• an2 therapeutics (antx) director receives 1,192-share stock grant as fees Stock Titan Sat, 11 Apr 2026 01:16:02 GMT
• dividend watch: whats the outlook for an2 therapeutics incs sector - market sentiment review & weekly watchlist of top performers baoquankhu1.vn Fri, 10 Apr 2026 15:18:22 GMT
• an2 therapeutics (antx) director receives 1,192-share stock grant as fees Stock Titan Fri, 10 Apr 2026 07:00:00 GMT
• director at an2 therapeutics (nasdaq: antx) awarded 3,775 shares Stock Titan Fri, 10 Apr 2026 07:00:00 GMT
• an2 therapeutics (antx) director receives 3,775-share fully vested grant Stock Titan Fri, 10 Apr 2026 07:00:00 GMT
• an2 therapeutics, inc. announces open market sale agreement with jefferies for common stock (8-k filing) Minichart Fri, 10 Apr 2026 07:00:00 GMT
• an2 therapeutics launches new $80 million atm program The Globe and Mail Fri, 10 Apr 2026 07:00:00 GMT
• an2 therapeutics enters $80 million at-the-market sales agreement with jefferies Investing.com Australia Fri, 10 Apr 2026 06:14:15 GMT
• according to the latest disclosure from the u.s. securities and exchange commission, biopharmaceutical company an2 therapeutics ha... Bitget Fri, 10 Apr 2026 00:22:30 GMT
• an2 therapeutics enters $80 million at-the-market sales agreement with jefferies Investing.com Thu, 09 Apr 2026 07:00:00 GMT
• an2 therapeutics (nasdaq: antx) launches new $80m at-the-market stock sale Stock Titan Thu, 09 Apr 2026 07:00:00 GMT
• an2 therapeutics inc may offer and sell up to $300 million of securities - sec filing marketscreener.com Thu, 09 Apr 2026 07:00:00 GMT
• an2 therapeutics (nasdaq: antx) launches $80m at‑the‑market share program Stock Titan Thu, 09 Apr 2026 07:00:00 GMT
• an2 therapeutics inc - enters open market sale agreement with jefferies for up to $80 million common stock - sec filing TradingView Thu, 09 Apr 2026 07:00:00 GMT
• according to the latest disclosure from the u.s. securities and exchange commission, biopharmaceutical company an2 therapeutics ha... Bitget Thu, 09 Apr 2026 07:00:00 GMT
• an2 therapeutics inc - may offer and sell up to $300 million of securities - sec filing TradingView Thu, 09 Apr 2026 07:00:00 GMT
• an2 therapeut inks $80m at-the-market sales agreement with jefferies, ends td cowen program TradingView Thu, 09 Apr 2026 07:00:00 GMT
• non tuberculous mycobacterial infections market: high-growth opportunities for investors to 2034 – delveinsight | insmed, an2 ther... Barchart.com Thu, 09 Apr 2026 07:00:00 GMT
• an2 therapeutics, inc. (antx) stock price, news, quote and history Yahoo Finance UK Thu, 02 Apr 2026 20:00:01 GMT
• quarterly earnings: is an2 therapeutics inc a top pick in the sector - 2026 chart watch & high accuracy trade signal alerts baoquankhu1.vn Thu, 02 Apr 2026 19:28:25 GMT
• energy moves: can an2 therapeutics inc sustain earnings growth - market activity recap & weekly setup with roi potential baoquankhu1.vn Thu, 02 Apr 2026 17:56:48 GMT
• an2 therapeutics (antx) upgraded to buy: what does it mean for the stock? Eastern Progress Thu, 02 Apr 2026 03:00:59 GMT
• pharma news: will an2 therapeutics inc stock recover after earnings - trade volume report & fast gain stock tips baoquankhu1.vn Wed, 01 Apr 2026 13:48:45 GMT
• an2 therapeutics launches phase 2 trial for lung infection drug by investing.com Investing.com South Africa Wed, 01 Apr 2026 06:56:45 GMT
• AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium abscessus... Business Wire Tue, 31 Mar 2026 07:00:00 GMT
• an2 therapeutics launches phase 2 trial for lung infection drug Investing.com Tue, 31 Mar 2026 07:00:00 GMT
• an2 therapeutics begins phase 2 trial of epetraborole for mycobacterium abscessus National Today Tue, 31 Mar 2026 07:00:00 GMT
• an2 therapeutics announces initiation of phase 2 trial of epetraborole TipRanks Tue, 31 Mar 2026 07:00:00 GMT
• activity recap: whats the fair value of an2 therapeutics inc stock - 2026 rallies & technical entry and exit alerts baoquankhu1.vn Sun, 29 Mar 2026 00:25:39 GMT
• activity recap: whats the fair value of an2 therapeutics inc stock - 2026 rallies & technical entry and exit alerts baoquankhu1.vn Sat, 28 Mar 2026 12:28:07 GMT
AN2 Therapeutics(NASDAQ:ANTX) 
Anthem, Inc., is a health benefits company in the United States. The company is headquartered in Indianapolis, Indiana.
Website: https://www.an2therapeutics.com/
Founded: 2017
IPO Price: $15 (Mar 25, 2022)
CEO: Eric E. Easom
Sector: TECHNOLOGY
Industry: GENERAL